“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

The announcement by Robert F. Kennedy Jr. is a major setback for the sector, as the technology has proven effective against ...

Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

(Alliance News) - Baillie Gifford US Growth Trust PLC on Tuesday announced that it outperformed the S&P index in its financial year, as it expects the year ahead to present "significant opportunities" ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into ...

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...

Central Texas doctor's offices and care centers have noticed the annual summer COVID-19 spike in cases has been happening in ...